1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Orthofix Medical Inc

Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with health care professionals to improve patients' lives. Headquartered in Lewisville, Texas, Orthofix's spine and orthopedic extremities products are distributed in more than 70 countries via the Company's sales representatives and distributors.


Orthofix Medical announces preliminary unaudited Q4 net sales of about $200.3M
Jan 09, 2024 13:12pm

Orthofix Medical Inc reports strong fourth quarter and full year net sales growth, with Bone Growth Therapies sales reaching record levels.

Source:Seeking Alpha
Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
Jan 09, 2024 13:00pm

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced preliminary unaudited fourth quarter 2023 net sales of approximately $200.3 million, an increase of 63.8% on a reported basis and 62.8% on a constant currency basis versus fourth quarter 2022. For the full year 2023, preliminary unaudited net sales were approximately $746.5 million, an increase of 62.0% on a reported basis and 61.5% on a constant currency basi

Source:Business Wire
Orthofix Medical appoints CEO, CFO
Jan 08, 2024 12:35pm

Orthofix Medical (OFIX) said on Monday that it has appointed Massimo Calafiore President and CEO, effective immediately.

Source:Seeking Alpha
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
Jan 08, 2024 12:00pm

Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that effective immediately, Massimo Calafiore has assumed the role of President and Chief Executive Officer (CEO) and as a member of the Orthofix Board of Directors. In conjunction with Mr. Calafiore stepping into his role as CEO, the Company has announced the appointment of Julie Andrews as Chief